Literature DB >> 10698990

Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France.

N Pradel1, V Livrelli, C De Champs, J B Palcoux, A Reynaud, F Scheutz, J Sirot, B Joly, C Forestier.   

Abstract

During a 1-year survey of Shiga toxin-producing Escherichia coli (STEC) prevalence in central France, 2,143 samples were investigated by PCR for Shiga toxin-encoding genes. A total of 330 (70%) of 471 fecal samples collected from healthy cattle at the Clermont-Ferrand slaughterhouse, 47 (11%) of 411 beef samples, 60 (10%) of 603 cheese samples, and 19 (3%) of 658 stool specimens from hospitalized children with and without diarrhea were positive for the stx gene(s). A STEC strain was isolated from 34% (162 of 471) of bovine feces, 4% (16 of 411) of beef samples, 1% (5 of 603) of cheese samples, and 1.5% (10 of 658) of stool specimens. Of the 220 STEC strains isolated, 34 (15%) harbored the stx(1) gene, 116 (53%) harbored the stx(2) gene, and 70 (32%) carried both the stx(1) and stx(2) genes. However, 32 (14.5%) were not cytotoxic for Vero cells. The eae gene, found in 12 (5%) of the 220 strains, was significantly associated with the stx(1) gene and with isolates from children. Sequences homologous to ehxA were found in 102 (46%) of the 220 strains. Thirteen serotypes, OX3:H2, O113:H21, O113:H4, OX3:H21, O6:H10, OX178:H19, O171:H2, O46:H38, O172:H21, O22:H16, O91:H10, O91:H21, and O22:H8, accounted for 102 (55%) of 186 typeable isolates, and only one strain (0.5% of the 186 STEC isolates from cattle), belonged to the O157:H7 serotype. We showed that the majority of the STEC isolates from cattle, beef, and cheese were not likely to be pathogenic for humans and that the STEC strains isolated from children in this study were probably not responsible for diarrheal disease. Finally, the strains associated with hemolytic-uremic syndrome in the same geographical area were shown to belong to particular subsets of the STEC population found in the bovine reservoir.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698990      PMCID: PMC86328     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Differentiation of Shiga toxin and Vero cytotoxin type 1 genes by polymerase chain reaction.

Authors:  D R Pollard; W M Johnson; H Lior; S D Tyler; K R Rozee
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

2.  Distribution and characterization of faecal verotoxin-producing Escherichia coli (VTEC) isolated from healthy cattle.

Authors:  M Blanco; J E Blanco; J Blanco; A Mora; C Prado; M P Alonso; M Mouriño; C Madrid; C Balsalobre; A Juárez
Journal:  Vet Microbiol       Date:  1997-03       Impact factor: 3.293

3.  Isolation of Escherichia coli serotype O157:H7 and other Shiga-like-toxin-producing E. coli from dairy cattle.

Authors:  J G Wells; L D Shipman; K D Greene; E G Sowers; J H Green; D N Cameron; F P Downes; M L Martin; P M Griffin; S M Ostroff
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

4.  EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V.

Authors:  W Brunder; H Schmidt; H Karch
Journal:  Mol Microbiol       Date:  1997-05       Impact factor: 3.501

5.  Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  J Yu; J B Kaper
Journal:  Mol Microbiol       Date:  1992-02       Impact factor: 3.501

6.  Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples.

Authors:  Denis Piérard; Daniel Stevens; Leo Moriau; Hermy Lior; Sabine Lauwers
Journal:  Clin Microbiol Infect       Date:  1997       Impact factor: 8.067

7.  Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.

Authors:  P Boerlin; S A McEwen; F Boerlin-Petzold; J B Wilson; R P Johnson; C L Gyles
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.

Authors:  S W Lindgren; A R Melton; A D O'Brien
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin.

Authors:  A O O'Brien; T A Lively; M E Chen; S W Rothman; S B Formal
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

10.  Prevalence of enterohemorrhagic Escherichia coli O157:H7 in a survey of dairy herds.

Authors:  T Zhao; M P Doyle; J Shere; L Garber
Journal:  Appl Environ Microbiol       Date:  1995-04       Impact factor: 4.792

View more
  78 in total

1.  Virulence properties and serotypes of Shiga toxin-producing Escherichia coli from healthy Australian cattle.

Authors:  Michael A Hornitzky; Barbara A Vanselow; Keith Walker; Karl A Bettelheim; Bruce Corney; Paul Gill; Graham Bailey; Steven P Djordjevic
Journal:  Appl Environ Microbiol       Date:  2002-12       Impact factor: 4.792

2.  Intestinal Shiga toxin-producing Escherichia coli bacteria mitigate bovine leukemia virus infection in experimentally infected sheep.

Authors:  Witold A Ferens; Rowland Cobbold; Carolyn J Hovde
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Presence of activatable Shiga toxin genotype (stx(2d)) in Shiga toxigenic Escherichia coli from livestock sources.

Authors:  Kari S Gobius; Glen M Higgs; Patricia M Desmarchelier
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model.

Authors:  Lucie Etienne-Mesmin; Valérie Livrelli; Maud Privat; Sylvain Denis; Jean-Michel Cardot; Monique Alric; Stéphanie Blanquet-Diot
Journal:  Appl Environ Microbiol       Date:  2010-12-03       Impact factor: 4.792

5.  Prevalence of shiga toxin-producing Escherichia coli in a diarrheagenic Tunisian population, and the report of isolating STEC O157:H7 in Tunis.

Authors:  Nazek Al-Gallas; Olfa Bahri; Ridha Ben Aissa
Journal:  Curr Microbiol       Date:  2006-11-17       Impact factor: 2.188

6.  Serotypes and virulence profiles of non-O157 Shiga toxin-producing Escherichia coli isolates from bovine farms.

Authors:  Aine Monaghan; Brian Byrne; Séamus Fanning; Torres Sweeney; David McDowell; Declan J Bolton
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

7.  Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates.

Authors:  Jean Pierre Girardeau; Alessandra Dalmasso; Yolande Bertin; Christian Ducrot; Séverine Bord; Valérie Livrelli; Christine Vernozy-Rozand; Christine Martin
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

8.  Presence and characterization of shiga toxin-producing Escherichia coli and other potentially diarrheagenic E. coli strains in retail meats.

Authors:  Xiaodong Xia; Jianghong Meng; Patrick F McDermott; Sherry Ayers; Karen Blickenstaff; Thu-Thuy Tran; Jason Abbott; Jie Zheng; Shaohua Zhao
Journal:  Appl Environ Microbiol       Date:  2010-01-15       Impact factor: 4.792

9.  Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.

Authors:  Jenny M Ritchie; Patrick L Wagner; David W K Acheson; Matthew K Waldor
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

10.  Serotypes and virulence gene profiles of shiga toxin-producing Escherichia coli strains isolated from feces of pasture-fed and lot-fed sheep.

Authors:  Steven P Djordjevic; Vidiya Ramachandran; Karl A Bettelheim; Barbara A Vanselow; Peter Holst; Graham Bailey; Michael A Hornitzky
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.